NextGen's 2010 Revenues Improve 4 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein biomarker and assay development firm NextGen Group announced on Friday that 2010 revenues increased 4 percent to a little more $1.2 million.

That compares to 2009 revenues of slightly less than $1.2 million.

For the year, the UK-based firm's net loss improved 8 percent to $3.3 million, or $.06 per share, from $3.6 million, $.11 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.